Alex M. Nadzan

3.6k total citations · 2 hit papers
68 papers, 2.9k citations indexed

About

Alex M. Nadzan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Alex M. Nadzan has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 19 papers in Organic Chemistry. Recurrent topics in Alex M. Nadzan's work include Neuropeptides and Animal Physiology (18 papers), Estrogen and related hormone effects (15 papers) and Retinoids in leukemia and cellular processes (14 papers). Alex M. Nadzan is often cited by papers focused on Neuropeptides and Animal Physiology (18 papers), Estrogen and related hormone effects (15 papers) and Retinoids in leukemia and cellular processes (14 papers). Alex M. Nadzan collaborates with scholars based in United States, United Kingdom and Canada. Alex M. Nadzan's co-authors include Richard A. Heyman, Marcus F. Boehm, Thomas Arrhenius, Jie‐Fei Cheng, Eric D. Bischoff, V N Reinhold, G. Büchi, Robert G. Croy, William F. Busby and John M. Essigmann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Alex M. Nadzan

68 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

1997 515 citations Ranjan Mukherjee, Peter J. Davies et al. Nature profile →
Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.

1977 389 citations Alex M. Nadzan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex M. Nadzan United States	26	1.7k	673	435	425	355	68	2.9k
Angelo Benedetti Italy	43	2.5k 1.4×	485 0.7×	283 0.7×	201 0.5×	212 0.6×	138	5.3k
Pia Hartzell Sweden	16	2.2k 1.3×	293 0.4×	134 0.3×	297 0.7×	364 1.0×	16	3.9k
Rayudu Gopalakrishna United States	29	2.5k 1.4×	162 0.2×	269 0.6×	445 1.0×	272 0.8×	82	4.3k
Syng‐Ook Lee South Korea	30	1.7k 1.0×	308 0.5×	199 0.5×	819 1.9×	518 1.5×	100	3.4k
W. C. Breckenridge Canada	34	1.9k 1.1×	213 0.3×	250 0.6×	360 0.8×	445 1.3×	97	4.4k
Tanihiro Yoshimoto Japan	30	1.0k 0.6×	265 0.4×	289 0.7×	116 0.3×	187 0.5×	68	2.5k
William E. Boeglin United States	37	1.9k 1.1×	712 1.1×	355 0.8×	79 0.2×	296 0.8×	92	4.2k
Donald J. Graves United States	35	2.2k 1.2×	335 0.5×	90 0.2×	156 0.4×	140 0.4×	95	4.2k
Tommaso Galeotti Italy	37	2.7k 1.6×	256 0.4×	120 0.3×	155 0.4×	747 2.1×	129	4.5k
Rosella Fulceri Italy	34	1.5k 0.8×	212 0.3×	172 0.4×	178 0.4×	111 0.3×	88	3.0k

Countries citing papers authored by Alex M. Nadzan

Since Specialization

Citations

This map shows the geographic impact of Alex M. Nadzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex M. Nadzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex M. Nadzan more than expected).

Fields of papers citing papers by Alex M. Nadzan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex M. Nadzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex M. Nadzan. The network helps show where Alex M. Nadzan may publish in the future.

Co-authorship network of co-authors of Alex M. Nadzan

This figure shows the co-authorship network connecting the top 25 collaborators of Alex M. Nadzan. A scholar is included among the top collaborators of Alex M. Nadzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex M. Nadzan. Alex M. Nadzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wallace, D. Michael A., Masayuki Haramura, Jie‐Fei Cheng, Thomas Arrhenius, & Alex M. Nadzan. (2007). Novel trifluoroacetophenone derivatives as malonyl-CoA decarboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(4). 1127–1130. 8 indexed citations

Farmer, Luc J., Stacie S. Canan Koch, C.‐K. HWANG, et al.. (2005). Aza-retinoids as novel retinoid X receptor-specific agonists. Bioorganic & Medicinal Chemistry Letters. 16(9). 2352–2356. 13 indexed citations

Cheng, Jie‐Fei, Mi Chen, David R. Wallace, et al.. (2004). Discovery and structure–activity relationship of coumarin derivatives as TNF-α inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(10). 2411–2415. 44 indexed citations

Zhou, Demin, Steven J Brown, M. R. PENA, et al.. (2004). Expression, purification, and characterization of human malonyl-CoA decarboxylase. Protein Expression and Purification. 34(2). 261–269. 18 indexed citations

Boehm, Marcus F., Patrick Fitzgerald, Aihua Zou, et al.. (1999). Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chemistry & Biology. 6(5). 265–275. 120 indexed citations

Mukherjee, Ranjan, Peter J. Davies, Diane L. Crombie, et al.. (1997). Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 386(6623). 407–410. 515 indexed citations breakdown →

Lala, Deepak S., Ranjan Mukherjee, Ira G. Schulman, et al.. (1996). Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature. 383(6599). 450–453. 134 indexed citations

Nadzan, Alex M., Marcus F. Boehm, Lin Zhang, et al.. (1995). DESIGN OF NOVEL RXR SELECTIVE RETINOIDS. European Journal of Medicinal Chemistry. 30. 519s–533s. 5 indexed citations

Rosen, Jon, Anthony J. Day, Todd K. Jones, et al.. (1995). The Intracellular Receptor and Signal Transducers and Activators of Transcription Factor Superfamilies: Novel Targets for Small-Molecule Drug Discovery. Journal of Medicinal Chemistry. 38(25). 4855–4874. 69 indexed citations

10.

Shue, Youe‐Kong, Michael D. Tufano, George M. Carrera, et al.. (1993). Double bond isosteres of the peptide bond: Synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs. Bioorganic & Medicinal Chemistry. 1(3). 161–171. 6 indexed citations

11.

Witte, David G., Alex M. Nadzan, Jean Martínez, Marc Rodriguez, & Chun Wel Lin. (1992). Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells. Peptides. 13(6). 1227–1232. 13 indexed citations

12.

Asin, Karen E., et al.. (1992). Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats. Brain Research. 571(1). 169–174. 38 indexed citations

13.

Carrera, George M., et al.. (1991). Novel methodology for the synthesis of trans-alkene dipeptide isosteres. The Journal of Organic Chemistry. 56(6). 2107–2111. 27 indexed citations

14.

Holladay, Mark W. & Alex M. Nadzan. (1991). ChemInform Abstract: Synthesis of α‐Benzyl γ‐Lactam, α‐Benzyl δ‐ Lactam, and α‐Benzylproline Derivatives as Conformationally Restricted Analogues of Phenylalaninamide.. ChemInform. 22(44). 1 indexed citations

15.

Shiosaki, Kazumi, et al.. (1991). Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-A receptor agonists. Journal of Medicinal Chemistry. 34(9). 2837–2842. 24 indexed citations

16.

Kerwin, James F., Alex M. Nadzan, Hana Kopecka, et al.. (1989). Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists. Journal of Medicinal Chemistry. 32(4). 739–742. 25 indexed citations

17.

Henschen, Andreas, et al.. (1988). Thyrotropin releasing hormone augments growth of spinal cord transplants in oculo. Experimental Neurology. 102(1). 125–129. 9 indexed citations

18.

Bianchi, Benedetta, D. A. Grant, Ted R. Miller, et al.. (1986). Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.. Journal of Pharmacology and Experimental Therapeutics. 236(3). 729–734. 21 indexed citations

19.

Buechi, George, Kerry W. Fowler, & Alex M. Nadzan. (1982). Photochemical epoxidation of aflatoxin B1 and sterigmatocystin: synthesis of guanine-containing adducts. Journal of the American Chemical Society. 104(2). 544–547. 17 indexed citations

20.

Tadanier, Jack, Jerry R. Martin, Alex M. Nadzan, et al.. (1981). 2-Substituted fortimicins by ring opening of 2-deoxy-1,2-epimino-2-epi-fortimicin B and by nucleophilic displacements of 2-O-(methylsulfonyl)fortimicin derivatives. Carbohydrate Research. 96(2). 185–203. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact